Reuters logo
BRIEF-Easywell Biomedical unit completes pilot SAD pharmacokinetic clinical study of parkinson treatment
November 29, 2016 / 6:25 AM / 10 months ago

BRIEF-Easywell Biomedical unit completes pilot SAD pharmacokinetic clinical study of parkinson treatment

Nov 29 (Reuters) - Easywell Biomedical Inc :

* Says its 50.2-percent-owned unit completed pilot SAD pharmacokinetic clinical study of parkinson treatment in Malaysia

* Says the unit will go on pilot MAD(multiple ascending dose) pharmacokinetic clinical study since December

Source text in Chinese:goo.gl/g0W9fk

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below